Inhibitory effect of Chaenomelis Fructus ethanol extract on receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis
3
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The fruit of Chaenomeles sinensis (Thouin) Koehne (Chaenomelis Fructus) known as “Mo-Gua” in Korea has been commonly used in traditional medicine to treat inflammatory diseases, such as sore throat. However, its effect on bone metabolism has not been elucidated yet. Here, we examined the effect of Chaenomelis Fructus ethanol extract (CFE) on receptor activator of nuclear factor (NF)-κB ligand (RANKL)-mediated osteoclast differentiation and formation. CF-E considerably inhibited osteoclast differentiation and tartrate-resistant acid phosphatase-positive multinuclear cell formation from bone marrow-derived macrophages and osteoclast precursor cells in a dose-dependent manner. In addition, the formation of actin rings and resorption pits were significantly suppressed in CF-E-treated osteoclasts as compared with the findings in non-treated control cells. Consistent with these phenotypic inhibitory results, the expressions of osteoclast differentiation marker genes (Acp5, Atp6v0d2 , Oscar, CtsK, and Tm7sf4) and Nfatc1 , a pivotal transcription factor for osteoclastogenesis, were markedly decreased by CF-E treatment. The inhibitory effect of CF-E on RANKL-induced osteoclastogenesis was associated with the suppression of NFATc1 expression, not by regulation of mitogen-activated protein kinases and NF-κB activation but by the inactivation of phospholipase C gamma 1 and 2. These results indicate that CF-E has an inhibitory effect on osteoclast differentiation and formation, and they suggest the possibility of CF-E as a traditional therapeutic agent against bone-resorptive diseases, such as osteoporosis, rheumatoid arthritis, and periodontitis.
Abstract
The fruit of Chaenomeles sinensis (Thouin) Koehne (Chaenomelis Fructus) known as “Mo-Gua” in Korea has been commonly used in traditional medicine to treat inflammatory diseases, such as sore throat. However, its effect on bone metabolism has not been elucidated yet. Here, we examined the effect of Chaenomelis Fructus ethanol extract (CFE) on receptor activator of nuclear factor (NF)-κB ligand (RANKL)-mediated osteoclast differentiation and formation. CF-E considerably inhibited osteoclast differentiation and tartrate-resistant acid phosphatase-positive multinuclear cell formation from bone marrow-derived macrophages and osteoclast precursor cells in a dose-dependent manner. In addition, the formation of actin rings and resorption pits were significantly suppressed in CF-E-treated osteoclasts as compared with the findings in non-treated control cells. Consistent with these phenotypic inhibitory results, the expressions of osteoclast differentiation marker genes (Acp5, Atp6v0d2 , Oscar, CtsK, and Tm7sf4) and Nfatc1 , a pivotal transcription factor for osteoclastogenesis, were markedly decreased by CF-E treatment. The inhibitory effect of CF-E on RANKL-induced osteoclastogenesis was associated with the suppression of NFATc1 expression, not by regulation of mitogen-activated protein kinases and NF-κB activation but by the inactivation of phospholipase C gamma 1 and 2. These results indicate that CF-E has an inhibitory effect on osteoclast differentiation and formation, and they suggest the possibility of CF-E as a traditional therapeutic agent against bone-resorptive diseases, such as osteoporosis, rheumatoid arthritis, and periodontitis.
참고문헌 (35)
- Matthew C. Walsh, "OSTEOIMMUNOLOGY: Interplay Between the Immune System and Bone Metabolism", Annual Review of Immunology, 24(1), pp.33~63 (2006), Annual Reviews[DOI]
- Boyle WJ, "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)[DOI]
- Matthew C. Walsh, "Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond", Frontiers in Immunology, 5, pp.511~ (2014), Frontiers Media SA[DOI]
- Teruhito Yamashita, "NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1", Journal of Biological Chemistry, 282(25), pp.18245~18253 (2007), Elsevier BV[DOI]
- S.E. Lee, "The phosphatidylinositol 3-Kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation", Bone, 30(1), pp.71~77 (2002), Elsevier BV[DOI]
- Sunil Srivastava, "Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-κB Ligand (RANKL)-induced JNK Activation", Journal of Biological Chemistry, 276(12), pp.8836~8840 (2001), Elsevier BV[DOI]
- A. Mocsai, "The immunomodulatory adapter proteins DAP12 and Fc receptor -chain (FcR ) regulate development of functional osteoclasts through the Syk tyrosine kinase", Proceedings of the National Academy of Sciences, 101(16), pp.6158~6163 (2004), Proceedings of the National Academy of Sciences[DOI]
- Takako Koga, "Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis", Nature, 428(6984), pp.758~763 (2004), Springer Science and Business Media LLC[DOI]
- Seoung Hoon Lee, "The Tec Family Tyrosine Kinase Btk Regulates RANKL-induced Osteoclast Maturation", Journal of Biological Chemistry, 283(17), pp.11526~11534 (2008), Elsevier BV[DOI]
- Dailing Mao, "PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2", Journal of Clinical Investigation, 116(11), pp.2869~2879 (2006), American Society for Clinical Investigation[DOI]
- Hiroshi Takayanagi, "Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems", Nature Reviews Immunology, 7(4), pp.292~304 (2007), Springer Science and Business Media LLC[DOI]
- Takako Negishi-Koga, "Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation", Immunological Reviews, 231(1), pp.241~256 (2009), Wiley[DOI]
- Hyunsoo Kim, "Tmem64 Modulates Calcium Signaling during RANKL-Mediated Osteoclast Differentiation", Cell Metabolism, 17(2), pp.249~260 (2013), Elsevier BV[DOI]
- 김정하, "Regulation of NFATc1 in Osteoclast Differentiation", 대한골대사학회지, 21(4), pp.233~241 (2014), 대한골대사학회[DOI]
- Keun Hyun Oh, "Biosynthesized gold and silver nanoparticles by aqueous fruit extract of Chaenomeles sinensis and screening of their biomedical activities", Artificial Cells, Nanomedicine, and Biotechnology, 46(3), pp.599~606 (2018), Informa UK Limited[DOI]
- MingHongLee, "Tissue Factor Inhibitory Flavonoids from the Fruits of Chaenomeles sinensis", Archives of Pharmacal Research, 25(6), pp.842~850 (2002), 대한약학회
- Chung Sub Kim, "Five New Oxylipins from Chaenomeles sinensis", Lipids, 49(11), pp.1151~1159 (2014), Wiley[DOI]
- Ming Hong Lee, "A new in vitro tissue factor inhibitory triterpene from the fruits of Chaenomeles sinensis", Planta Medica, 69(4), pp.327~331 (2003), Georg Thieme Verlag KG[DOI]
- Hui Du, "Polyphenols and triterpenes from Chaenomeles fruits: Chemical analysis and antioxidant activities assessment", Food Chemistry, 141(4), pp.4260~4268 (2013), Elsevier BV[DOI]
- Sandesh Sancheti, "Antihyperglycemic, antihyperlipidemic, and antioxidant effects of Chaenomeles sinensis fruit extract in streptozotocin-induced diabetic rats", European Food Research and Technology, 231(3), pp.415~421 (2010), Springer Science and Business Media LLC[DOI]
- Reiko Sawai-Kuroda, "A polyphenol-rich extract from Chaenomeles sinensis (Chinese quince) inhibits influenza A virus infection by preventing primary transcription in vitro", Journal of Ethnopharmacology, 146(3), pp.866~872 (2013), Elsevier BV[DOI]
- Jing Miao, "Chemical composition and bioactivities of two common Chaenomeles fruits in China: Chaenomeles speciosa and Chaenomeles sinensis", Journal of Food Science, 81(8), pp.H2049~H2058 (2016), Wiley[DOI]
- Li Zhang, "Antioxidant, Anti-Inflammatory and Anti-Influenza Properties of Components from Chaenomeles speciosa", Molecules, 15(11), pp.8507~8517 (2010), MDPI AG[DOI]
- Qing Zhu, "Ethanolic extract and water-soluble polysaccharide from Chaenomeles speciosa fruit modulate lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophage cells", Journal of Ethnopharmacology, 144(2), pp.441~447 (2012), Elsevier BV[DOI]
- Keun Ha Park, "Pueraria lobate inhibits RANKL-mediated osteoclastogenesis via downregulation of CREB", PGC1β, NFATc1signaling, pp.The American Journal of Chinese Medicine, 2017[DOI]
- Jia M, "Potential antiosteoporotic agents from plants : a comprehensive review", Evid Based Complement Alternat Med, 2012, pp.364604~ (2012)[DOI]
- 이지연, "Methanol Extract of Croton Pycnanthus Benth. Inhibits Osteoclast Differentiation by Suppressing the MAPK and NF-κB Signaling Pathways", 대한골대사학회지, 21(4), pp.269~275 (2014), 대한골대사학회[DOI]
- Jeong-Mi Kim, "Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB", NFATc1 pathway in mouse bone marrow cells, 2017, pp.17(1), 164~[DOI]
- 박상윤, "Quantitative Analysis of Ursolic Acid and Euscaphic Acid in Chaenomelis Fructus by HPLC-Evaporative Light Scattering Detection", Bulletin of the Korean Chemical Society, 35(7), pp.2210~2212 (2014), 대한화학회[DOI]
- S LEE, "Anabolic activity of ursolic acid in bone: Stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo", Pharmacological Research, 58(5-6), pp.290~296 (2008), Elsevier BV[DOI]
- Chuan Jiang, "Inhibitory effects of ursolic acid on osteoclastogenesis and titanium particle-induced osteolysis are mediated primarily via suppression of NF-κB signaling", Biochimie, 111, pp.107~118 (2015), Elsevier BV[DOI]
- Ju-Young Kim, "Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLCγ2–Ca2+-NFATc1 signaling, and suppresses bone loss in mice", Bone, 60, pp.104~111 (2014), Elsevier BV[DOI]
- Alice Wattel, "Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF?B and AP-1", Journal of Cellular Biochemistry, 92(2), pp.285~295 (2004), Wiley[DOI]
- Ji-Won Lee, "Inhibitory effect of luteolin on osteoclast differentiation and function", Cytotechnology, 61(3), pp.125~134 (2009), Springer Science and Business Media LLC[DOI]
- Ru-Wei Lin, "(−)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-κB", Biochemical and Biophysical Research Communications, 379(4), pp.1033~1037 (2009), Elsevier BV[DOI]
